Finance

Lists
OBAT:IDX
Brigit Biofarmaka Teknologi Tbk PT
218,00 IDR
+0,93%
(+2,00) 1D
2 ოქტ, 16:00:04 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for OBAT...
Open
216 IDR
High
220 IDR
Low
212 IDR
Mkt. cap
148,32 მლრ.
Avg. vol.
633,99 ათ.
Volume
62,00 ათ.
Dividend
3,46%
Quarterly dividend
2 IDR
Ex-dividend date
22 მაი. 2026
P/E ratio
11,64
52-wk high
550 IDR
52-wk low
190 IDR
EPS
19 IDR
Shares outstanding
680,38 მლნ.
No. of employees
17
Open
216 IDR
High
220 IDR
Low
212 IDR
Mkt. cap
148,32 მლრ.
Avg. vol.
633,99 ათ.
Volume
62,00 ათ.
Dividend
3,46%
Quarterly dividend
2 IDR
Ex-dividend date
22 მაი. 2026
P/E ratio
11,64
52-wk high
550 IDR
52-wk low
190 IDR
EPS
19 IDR
Shares outstanding
680,38 მლნ.
No. of employees
17
News stories
From web sources and news partners
News.com.au
News.com.au
·
47 წუთის წინ
Giants ring bell at NYSE for 40th anniversary of SB 21
Simply Wall Street
Simply Wall Street
·
17 წუთის წინ
Ionis Pharmaceuticals Fell 45% With The Case Still Split
Moomoo
Moomoo
·
44 წუთის წინ
Chip-Led Rally Lifts Nasdaq; Tesla Jumps 4.65%
CNBC
CNBC
·
6 საათის წინ
Friday's rally in the S&P 500 might not be enough, but Linde is out of this world
About Brigit Biofarmaka Teknologi Tbk PT
CEO-
Employees17
Founded2015
Headquarters-
SectorPersonal care products
Websitebrigit.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
38,18 მლრდ.
45,37 მლრდ.
43,82 მლრდ.
45,18 მლრდ.
Cost of goods sold
18,76 მლრდ.
35,71 მლრდ.
28,17 მლრდ.
28,27 მლრდ.
Cost of revenue
18,76 მლრდ.
35,71 მლრდ.
28,17 მლრდ.
28,27 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,92 მლრდ.
6,42 მლრდ.
10,53 მლრდ.
10,81 მლრდ.
Operating expense
8,67 მლრდ.
7,08 მლრდ.
10,83 მლრდ.
10,70 მლრდ.
Total operating expenses
27,43 მლრდ.
42,80 მლრდ.
39,00 მლრდ.
38,97 მლრდ.
Operating income
10,75 მლრდ.
2,57 მლრდ.
4,83 მლრდ.
6,21 მლრდ.
Other non operating income
-54,54 მლნ.
165,04 მლნ.
242,73 მლნ.
-92,66 მლნ.
EBT including unusual items
10,67 მლრდ.
3,27 მლრდ.
4,87 მლრდ.
5,83 მლრდ.
EBT excluding unusual items
10,69 მლრდ.
3,25 მლრდ.
4,87 მლრდ.
5,83 მლრდ.
Income tax expense
4,46 მლრდ.
2,80 მლრდ.
-
1,39 მლრდ.
Effective tax rate
41,86%
85,71%
-
23,88%
Other operating expenses
751,69 მლნ.
660,16 მლნ.
296,55 მლნ.
-105,38 მლნ.
Net income
2,38 მლრდ.
2,47 მლრდ.
2,92 მლრდ.
4,40 მლრდ.
Net profit margin
6,22%
5,44%
6,65%
9,75%
Earnings per share
-
-
-
-
Interest and investment income
149,39 მლნ.
1,36 მლრდ.
72,42 მლნ.
13,58 მლნ.
Interest expense
-156,33 მლნ.
-1,34 მლრდ.
-266,58 მლნ.
-301,05 მლნ.
Net interest expenses
-6,94 მლნ.
19,56 მლნ.
-194,16 მლნ.
-287,47 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
11,71 მლრდ.
2,63 მლრდ.
5,73 მლრდ.
7,38 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები